Sales rise 13.78% to Rs 1302.65 crore
Net profit of Ajanta Pharma rose 3.89% to Rs 255.34 crore in the quarter ended June 2025 as against Rs 245.77 crore during the previous quarter ended June 2024. Sales rose 13.78% to Rs 1302.65 crore in the quarter ended June 2025 as against Rs 1144.92 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 1302.65 | 1144.92 | 14 |
OPM % | 26.97 | 28.85 | - |
PBDT | 372.42 | 356.09 | 5 |
PBT | 331.13 | 322.12 | 3 |
NP | 255.34 | 245.77 | 4 |
Powered by Capital Market - Live News